GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SynCore Biotechnology Co Ltd (ROCO:4192) » Definitions » Cyclically Adjusted PB Ratio

SynCore Biotechnology Co (ROCO:4192) Cyclically Adjusted PB Ratio : 1.18 (As of May. 24, 2024)


View and export this data going back to 2014. Start your Free Trial

What is SynCore Biotechnology Co Cyclically Adjusted PB Ratio?

As of today (2024-05-24), SynCore Biotechnology Co's current share price is NT$44.35. SynCore Biotechnology Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was NT$37.59. SynCore Biotechnology Co's Cyclically Adjusted PB Ratio for today is 1.18.

The historical rank and industry rank for SynCore Biotechnology Co's Cyclically Adjusted PB Ratio or its related term are showing as below:

ROCO:4192' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.92   Med: 1.22   Max: 2.44
Current: 1.18

During the past years, SynCore Biotechnology Co's highest Cyclically Adjusted PB Ratio was 2.44. The lowest was 0.92. And the median was 1.22.

ROCO:4192's Cyclically Adjusted PB Ratio is ranked better than
60.43% of 652 companies
in the Biotechnology industry
Industry Median: 1.74 vs ROCO:4192: 1.18

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

SynCore Biotechnology Co's adjusted book value per share data for the three months ended in Mar. 2024 was NT$9.931. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is NT$37.59 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


SynCore Biotechnology Co Cyclically Adjusted PB Ratio Historical Data

The historical data trend for SynCore Biotechnology Co's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SynCore Biotechnology Co Cyclically Adjusted PB Ratio Chart

SynCore Biotechnology Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 2.35 1.02

SynCore Biotechnology Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.83 1.67 1.14 1.02 1.02

Competitive Comparison of SynCore Biotechnology Co's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, SynCore Biotechnology Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SynCore Biotechnology Co's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, SynCore Biotechnology Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where SynCore Biotechnology Co's Cyclically Adjusted PB Ratio falls into.



SynCore Biotechnology Co Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

SynCore Biotechnology Co's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=44.35/37.59
=1.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SynCore Biotechnology Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, SynCore Biotechnology Co's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=9.931/131.7762*131.7762
=9.931

Current CPI (Mar. 2024) = 131.7762.

SynCore Biotechnology Co Quarterly Data

Book Value per Share CPI Adj_Book
201406 34.372 100.560 45.042
201409 26.779 100.428 35.138
201412 56.279 99.070 74.859
201503 66.212 99.621 87.584
201506 57.737 100.684 75.567
201509 49.940 100.392 65.552
201512 52.894 99.792 69.847
201603 47.456 100.470 62.243
201606 42.246 101.688 54.746
201609 52.807 101.861 68.316
201612 50.964 101.863 65.930
201703 47.247 102.862 60.528
201706 44.079 103.349 56.203
201709 41.707 104.136 52.777
201712 38.004 104.011 48.149
201803 35.989 105.290 45.042
201806 31.090 106.317 38.535
201809 36.989 106.507 45.765
201812 31.235 105.998 38.831
201903 28.739 107.251 35.311
201906 23.042 108.070 28.097
201909 28.050 108.329 34.121
201912 23.161 108.420 28.150
202003 20.017 108.902 24.222
202006 26.760 108.767 32.421
202009 23.038 109.815 27.645
202012 19.381 109.897 23.240
202103 26.851 111.754 31.662
202106 24.035 114.631 27.630
202109 16.982 115.734 19.336
202112 14.182 117.630 15.888
202203 12.928 121.301 14.044
202206 11.598 125.017 12.225
202209 10.568 125.227 11.121
202212 7.973 125.222 8.390
202303 7.155 127.348 7.404
202306 6.343 128.729 6.493
202309 5.371 129.860 5.450
202312 10.156 129.419 10.341
202403 9.931 131.776 9.931

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


SynCore Biotechnology Co  (ROCO:4192) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


SynCore Biotechnology Co Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of SynCore Biotechnology Co's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


SynCore Biotechnology Co (ROCO:4192) Business Description

Traded in Other Exchanges
N/A
Address
No.84 Zhongshan Road, Zhongshan Village, Dongshan Township, Yilan, TWN, 269
SynCore Biotechnology Co Ltd is a biopharmaceutical company. Its pipeline products concentrate on the ophthalmology, oncology, and dermatology fields. The pipeline products of the company include SB01 and 02, SB03, SB04, and SB05. It is engaged in drug development and sale, food advisory, medicine inspection, biotechnology service and intellectual property. It operates in a single industry, the new drug development.

SynCore Biotechnology Co (ROCO:4192) Headlines

No Headlines